Algernon Pharmaceuticals Inc (CNSX:AGN) (OTCMKTS:AGNPF) (FRA:AGW) CEO Christopher J. Moreau joined Midas Letter to discuss scaling up manufacturing of NP-120 (Ifenprodil) to prepare for Coronavirus and Acute Lung Injury clinical trials. Ifenprodil has been proven to increase survivability of H5N1 (Asian Avian Influenza or Bird Flu) by 40% and Algernon expects to see similar response in COVID-19 (Corona virus) patients. The company have received positive feedback from the U.S. Food and Drug Administration (FDA) regarding its plans to conduct a phase 2 COVID-19 clinical trial using its repurposed drug NP-120 (Ifenprodil). Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on identifying generic drugs with the potential to treat other diseases. If a drug is found to have properties to treat other illnesses, the drug can then be move into clinical trials more efficiently as pre-clinical testing has already been completed. Watch the full interview to learn about the drug Ifenprodil and its applications in treating Corona virus patients.

Original article: Ifenprodil: The Specialized Drug Treating Coronavirus©2020 Midas Letter. All Rights Reserved.

Midas Letter CEO James West, Wealthpress Head Trader Roger Scott and Future of Wealth Head Trader Lance Ippolito interpret market reaction on the first trading day back from Easter holiday after last weeks record rally in US equities. The large uptrend stemmed from the levelling off in the rate of COVID-19 infections, the massive Fed stimulus being injected into the economy and the historic resolution between Saudi Arabia, Russia, and USA to cut oil output. The trio analyze why U.S. stocks headed lower to start the week and what to look for as earnings season gets under way.

Original article: What to Look for in First Trading Day after Easter©2020 Midas Letter. All Rights Reserved.

Wealthpress Head Trader Roger Scott joined Midas Letter to discuss the best market action in US equities since the Great Depression. The S&P 500 rose 1.5% on Thursday bringing weekly gains to 12.1% – the best one-week gain in the index in 46 years. The rise in the markets comes off the back of the worst job claims news since 1948, where a staggering 6.6. million people sought unemployment benefits last week. The total statistic figures for unemployment claims since the COVID-19 virus outbreak has now hit a record 16.8 million. The market is ignoring macroeconomic headlines and focusing solely on the Corona Virus cases which in recent days have been reported lower than expectations. Watch the full interview for investment ideas related to companies looking for a COVID-19 cure and how market expectations and sentiment are reacting to the Fed rescue efforts in the short term.

Original article: S&P Posts Best Week in 46 years Amid Record US Jobless Aid©2020 Midas Letter. All Rights Reserved.

Midas Letter CEO James West, Wealthpress Head Trader Roger Scott and Future of Wealth Head Trader Lance Ippolito sit down to discuss current affairs in the economy and provide insight into what might move markets further this week. The Coronavirus is still the main catalyst in markets – traders are taking some positives as Italy’s daily coronavirus death toll fell to lowest in 3 weeks. However, the US has warned the worst is still yet to come. Watch the full interview to learn how the stock market is reacting in the short-term to Coronavirus headlines, the lack of specifics outlined in the Fed stimulus package, and macroeconomic future outlooks.

Original article: Will this Stock Market Rally Continue?©2020 Midas Letter. All Rights Reserved.

Wealthpress Head Trader Roger Scott joined Midas Letter to discuss how traders can potentially make large profits during the current uncertain economic times by utilizing options trading. Many investors avoid options and other derivative trading strategies believing them to be difficult to understand, but Roger Scott breaks how the instrument can be less risky than regular equity trading while potentially delivering higher percentage returns. Another strategy the Wealthpress Head Trader recommends as a viable alternative strategy is using inverse ETF’s. Inverse ETF investments provide a way for traders to profit from a decline in the value of an underlying benchmark index such as the S&P 500. Watch the full interview for further insights into how COVID-19 is effecting markets and approaches to profit from the impact.

Original article: The Advantage of Trading Options in Times of Crisis©2020 Midas Letter. All Rights Reserved.

Future of Wealth Head Trader Lance Ippolito joined Midas Letter to discuss the current weakening of US equities heading the second quarter of 2020. US President, Donald Trump has warned of a much longer economic impact and markets have reacted accordingly. Predictions estimate that the number of Corona Virus (COVID-19) cases are yet to hit their peak until at least the end of this month. With current fears in the world and the coinciding economic struggle, Lance is very concerned with the lack of liquidity and volume in markets and options trading. Lance has seen opportunity as the VIX Index (a popular measure of the stock market’s expectation of volatility based on S&P 500 index options) has decreased which made put options (contract where traders believe the underlying stock price will drop below the exercise price of the option) cheaper. Watch the full interview for stock market insights and how the Future of Wealth Head Trader is investing during these uncertain times.

Original article: Stock Market Insights on Historic Q1 2020©2020 Midas Letter. All Rights Reserved.

Ideanomics (NASDAQ:IDEX) Chairman Bruno Wu joined Midas Letter to discuss monetizing the adoption of commercial electric vehicles, the associated energy consumption and developing next generation financial technology (Fintech) products. Last year, the company the formed its Mobile Energy Global (MEG) division enabling commercial fleet operators to migrate from gasoline and diesel-powered vehicles into electric vehicles. The commercial fleet segments MEG is focused on are Heavy Trucks, Buses & Coaches, Logistical Vans and Taxis. Ideanomics also provide financial services solutions powered by artificial intelligence (AI) and blockchain making these tools more accessible to a variety of industries and global markets. Watch the full interview to learn how the CEO wants to turn the company into the Exxon Mobil (NYSE:XOM) of the mobile energy transformation and Fintech revolution.

Original article: The Exxon Mobil of Electric Vehicle and FinTech Revolution©2020 Midas Letter. All Rights Reserved.

Canadian Palladium Resources Inc (CNSX:BULL) (OTCMKTS:DCNNF) (FRA:DCR1) CEO Wayne Tisdale joined Midas Letter to discuss the company’s unique deposits that could generate 7 grams per tonne of palladium. The company hope to double the drilling on the property in the next few months and will mine more than 1.5 million ounces. The CEO attributes the shortage of palladium in the world and Chinese emission increases for the increase of palladium prices – which has gone up 25 percent since the beginning of 2020. Watch the entire interview to learn more about Canadian Palladium projects as well as the future direction of Palladium.

Original article: Coronavirus Fuelling Demand for Precious Metals Like Palladium©2020 Midas Letter. All Rights Reserved.

Kevin O’Leary, the Canadian businessman, author, politician, and television personality, joins James West to discuss teaming up with Bruce Linton, co-founder of Canopy Growth Corp (NYSE:CGC) (TSX:WEED) and betting on a new emerging industry. That new market being psychedelic’s. Not recreational drugs but compounds with real medical properties and applications. Certain psychedelic’s have been shown to help patients suffering from depression, anxiety, alcohol and opioid addictions. Mr. Wonderful made a strategic investment in MindMed (NEO:MMED) in its $24.2 million funding round before going public on the NEO Exchange. The company’s main priority is to address opioid addiction by developing a non-hallucinogenic version of the psychedelic ibogaine. Mr. O’Leary has bet on MindMed because of its management team, the patients they can help using psychedelics and their disassociation with recreational drugs. Watch the full interview to find out all the reasons behind Mr. O’Leary next big investment into the psychedelic space.

Original article: Kevin O’Leary Betting on New Emerging Industry©2020 Midas Letter. All Rights Reserved.

You may remember Midas Letter interviewing Elias “The Spartan” Theodorou fighting against the stigma of medical cannabis in professional sports about a year ago (Linked here). The Canadian mixed martial artist is now back in studio after his latest victory. However, this time it isn’t by knock-out or submission… he just won a six-year battle to use medical cannabis. He is now the only professional athlete in the world who has an exemption to use medical cannabis while competing in a sport. The Former UFC star is hoping this victory sets precedent for all other athletes to apply for their own therapeutic use exemption if appropriate. Watch the full interview to hear about Elias’ uphill battles as a Canadian to exercise his fundamental rights to medicate, as prescribed by his doctor.

Original article: 1st Sanctioned Cannabis Athlete in Professional Sport©2020 Midas Letter. All Rights Reserved.